Harbin Medisan Pharmaceutical Co., Ltd. announced at the EGM held on November 25, 2022 that the company approved election of Zhuge Guomin, Liang Yanfei and Zhu Zihong as non-independent directors, Liu Hongquan as independent director and Zhai Yuping and Gao Lu as non-employee supervisors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.12 CNY | +0.80% | -1.56% | -25.86% |
Apr. 26 | Harbin Medisan Pharmaceutical Co., Ltd. Proposes Final Dividend for 2023 | CI |
Apr. 26 | Medisan Pharma's Potassium Chloride Injection Passes Drug Regulator's Evaluation | MT |
1st Jan change | Capi. | |
---|---|---|
-25.86% | 434M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- 002900 Stock
- News Harbin Medisan Pharmaceutical Co., Ltd.
- Harbin Medisan Pharmaceutical Co., Ltd. Approves Management Appointments